Search clinical trials for: BTCT4465A (Mosunetuzumab) IV
Total 3233 results
-
Genentech, Inc.Active, not recruitingLymphocytic Leukemia, Chronic | Lymphoma, Non HodgkinUnited States, Korea, Republic of, Australia, United Kingdom, Germany, Canada, Spain
-
Washington University School of MedicineGenentech, Inc.RecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed B-Cell Lymphoma | Follicular Lymphoma Grade 3BUnited States
-
Washington University School of MedicineGenentech, Inc.RecruitingB Cell Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | Aggressive Lymphoma | Follicular Lymphoma Grade 3United States
-
Hoffmann-La RocheActive, not recruitingB-cell Non-Hodgkin LymphomaUnited States, Canada, Belgium, Spain, United Kingdom
-
Washington University School of MedicineGenentech, Inc.; Institute for Follicular LymphomaRecruitingLymphoma, Follicular | Follicular LymphomaUnited States
-
Abramson Cancer Center at Penn MedicineGenentech, Inc.RecruitingDLBCL - Diffuse Large B Cell Lymphoma | Large B-cell LymphomaUnited States
-
Hoffmann-La RocheActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Israel, Spain, Korea, Republic of, Poland, Taiwan
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
Hoffmann-La RocheActive, not recruitingFollicular LymphomaUnited Kingdom, United States, China, France, Spain
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Follicular LymphomaUnited States
-
Genentech, Inc.RecruitingNon-Hodgkin LymphomaUnited States, Puerto Rico
-
Hoffmann-La RocheActive, not recruitingSystemic Lupus ErythematosusUnited States, Poland, Georgia, Moldova, Republic of
-
M.D. Anderson Cancer CenterGenentech, Inc.WithdrawnRefractory B-cell Acute Lymphoblastic LeukemiaUnited States
-
University of WashingtonGenentech, Inc.RecruitingMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone...United States
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; Genentech, Inc.Recruiting
-
Hoffmann-La RocheRecruitingNon-Hodgkin LymphomaUnited States, Israel, Italy, Spain, United Kingdom
-
University of WashingtonNot yet recruitingAnn Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal Zone Lymphoma and other conditionsUnited States
-
Hoffmann-La RocheRecruitingChronic Lymphocytic LeukemiaSpain, Australia, Germany, United States, Italy, United Kingdom, France
-
National Cancer Institute (NCI)RecruitingHigh Grade B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
-
Taipei City HospitalNot yet recruitingAcute Flank PainTaiwan
-
Eli Lilly and CompanyCompletedPsoriasisUnited States
-
Healthgen Biotechnology Corp.Completed
-
Healthgen Biotechnology Corp.RecruitingEmphysema Secondary to Congenital AATDUnited States
-
Kyowa Kirin Co., Ltd.Terminated
-
Eli Lilly and CompanyCompletedAlzheimer DiseaseUnited States, Japan
-
Asir John SamuelMaharishi Markendeswar University (Deemed to be University)RecruitingAcute Coronary SyndromeIndia
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
C. R. BardCompletedVascular Access ComplicationUnited States
-
WockhardtCompletedBioavailabilityUnited States
-
Eli Lilly and CompanyCompleted
-
Prometheus Biosciences, Inc., a subsidiary of Merck...Altasciences Company Inc.Completed
-
OculisNeurotrialsRecruitingOptic Neuritis | Optic; Neuritis, With DemyelinationFrance
-
Gmax Biopharm LLC.RecruitingPulmonary Arterial HypertensionUnited States, China
-
Flame BiosciencesWithdrawnGastric Cancer | Solid Tumor | Pancreas Cancer
-
Qilu Pharmaceutical Co., Ltd.Completed
-
BayerRecruitingPulmonary Hypertension Due to Left Heart DiseaseGermany
-
Alexion Pharmaceuticals, Inc.Syneos HealthCompleted
-
Eli Lilly and CompanyCompleted
-
Universitaire Ziekenhuizen KU LeuvenBEDAL; RemedusTerminatedNeoplasms | Cystic Fibrosis | Pulmonary HypertensionBelgium
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Mexico, Italy, United Kingdom
-
William Beaumont HospitalsCompletedVascular Access DevicesUnited States
-
International AIDS Vaccine InitiativeBeth Israel Deaconess Medical Center; Ragon Institute of MGH, MIT and Harvard; University of Texas Health, Houston AIDS Research Team (HART) and other collaboratorsCompleted
-
Edesa Biotech Inc.JSS Medical Research Inc.Recruiting
-
Astria Therapeutics, Inc.Completed